Selank is studied in preclinical tuftsin-derived peptide models involving neuronal, immune-signaling, and gene-expression pathways.
- Tuftsin-derived signaling
- Neuronal cell models
- Immune-signaling models
Selank is the tuftsin-related listing
Selank is studied in tuftsin-derived peptide models that include neuronal and immune-signaling pathways. It is not Semax.
Task 121837, analyzed March 17, 2026, prints 11.55 mg and purity 99.793%.
Matched price, unmatched report
Semax is also $34.99 and prints a different identity line. Use task 121837 only for this vial.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
Selank 10 mg research questions
What does the Selank report print?
11.55 mg and purity 99.793%, task 121837.
What is the labeled amount?
10 mg.
References and further reading
- PubMed literature index — Selank 10 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.